Comparative efficacy of caffeic acid phenethyl ester (CAPE), olopatadine hydrochloride, and dexamethasone sodium phosphate in experimental allergic conjunctivitis

dc.contributor.authors	Aydin, E; Demir, HD; Ozyurt, H; Erkorkmaz, U
dc.date.accessioned	2020-02-27T07:16:47Z
dc.date.available	2020-02-27T07:16:47Z
dc.date.issued	2010
dc.identifier.citation	Aydin, E; Demir, HD; Ozyurt, H; Erkorkmaz, U (2010). Comparative efficacy of caffeic acid phenethyl ester (CAPE), olopatadine hydrochloride, and dexamethasone sodium phosphate in experimental allergic conjunctivitis. TURKISH JOURNAL OF MEDICAL SCIENCES, 40, 612-605
dc.identifier.issn	1300-0144
dc.identifier.uri	https://doi.org/10.3906/sag-0805-20
dc.identifier.uri	https://hdl.handle.net/20.500.12619/65178
dc.description.abstract	Conclusion: This study demonstrated that 1% CAPE was as clinically efficacious as 0 1% olopatadine and 0 1% dexamethasone. Thus, 1% CAPE may be an alternative to 0 1% olopatadine and 0 1% dexamethasone in the management of acute allergic reactions
dc.language	English
dc.publisher	TUBITAK SCIENTIFIC & TECHNICAL RESEARCH COUNCIL
dc.title	Comparative efficacy of caffeic acid phenethyl ester (CAPE), olopatadine hydrochloride, and dexamethasone sodium phosphate in experimental allergic conjunctivitis
dc.identifier.volume	40
dc.identifier.startpage	605
dc.identifier.endpage	612
dc.contributor.department	Sakarya Üniversitesi/Tıp Fakültesi/Temel Tıp Bilimleri Bölümü
dc.contributor.saüauthor	Erkorkmaz, Ünal
dc.relation.journal	TURKISH JOURNAL OF MEDICAL SCIENCES
dc.identifier.wos	WOS:000281832100014
dc.identifier.doi	10.3906/sag-0805-20
dc.contributor.author	Erkorkmaz, Ünal